Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) Net Income towards Common Stockholders (2016 - 2023)

Historic Net Income towards Common Stockholders for Aethlon Medical (AEMD) over the last 13 years, with Q1 2023 value amounting to -$2.5 million.

  • Aethlon Medical's Net Income towards Common Stockholders rose 3454.55% to -$2.5 million in Q1 2023 from the same period last year, while for Dec 2023 it was -$2.5 million, marking a year-over-year increase of 8023.83%. This contributed to the annual value of -$13.7 million for FY2025, which is 1223.98% down from last year.
  • Latest data reveals that Aethlon Medical reported Net Income towards Common Stockholders of -$2.5 million as of Q1 2023, which was up 3454.55% from -$2.8 million recorded in Q4 2022.
  • Over the past 5 years, Aethlon Medical's Net Income towards Common Stockholders peaked at -$820939.0 during Q4 2019, and registered a low of -$3.8 million during Q3 2022.
  • Its 5-year average for Net Income towards Common Stockholders is -$2.2 million, with a median of -$2.1 million in 2022.
  • In the last 5 years, Aethlon Medical's Net Income towards Common Stockholders surged by 5933.89% in 2019 and then plummeted by 19775.54% in 2020.
  • Aethlon Medical's Net Income towards Common Stockholders (Quarter) stood at -$820939.0 in 2019, then tumbled by 197.76% to -$2.4 million in 2020, then dropped by 3.42% to -$2.5 million in 2021, then dropped by 12.73% to -$2.8 million in 2022, then grew by 13.05% to -$2.5 million in 2023.
  • Its Net Income towards Common Stockholders stands at -$2.5 million for Q1 2023, versus -$2.8 million for Q4 2022 and -$3.8 million for Q3 2022.